MedTrace Logo

Image-guided Cryoablation of Head, Neck and Spine Tumors

NCT02085941 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2022-08-15

Study results available
· View outcomes & findings →

Summary

This research study is evaluating a procedure called cryoablation (the removal of diseased tissue using extreme freezing temperatures) as a possible treatment for head, neck and spine tumors.

Conditions

  • Head and Neck Neoplasms
  • Malignant Neoplasm of Vertebral Column

Interventions

DEVICE

Cryoablation

Cryoablation using 17G Galil cryoprobe

DEVICE

Biopsy

Biopsy using 18G Temno core biopsy needle

Sponsors & Collaborators

Principal Investigators

  • Thomas Lee, MD · Brigham and Women's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2021-07-31
Completion
2021-07-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02085941 on ClinicalTrials.gov